Shanghai INT Medical Instruments Co., Ltd. (HKG: 1501)

Shanghai INT Medical Instruments Statistics

Total Valuation

Shanghai INT Medical Instruments has a market cap or net worth of HKD 5.28 billion. The enterprise value is 4.98 billion.

Market Cap	5.28B
Enterprise Value	4.98B

Important Dates

The next estimated earnings date is Tuesday, November 19, 2024.

Earnings Date	Nov 19, 2024
Ex-Dividend Date	May 30, 2024

Share Statistics

Shanghai INT Medical Instruments has 176.00 million shares outstanding. The number of shares has decreased by -0.79% in one year.

Shares Outstanding	176.00M
Shares Change (YoY)	-0.79%
Shares Change (QoQ)	-4.37%
Owned by Insiders (%)	29.61%
Owned by Institutions (%)	11.86%
Float	29.59M

Valuation Ratios

The trailing PE ratio is 27.59 and the forward PE ratio is 23.52.

PE Ratio	27.59
Forward PE	23.52
PS Ratio	5.73
PB Ratio	2.93
P/FCF Ratio	55.03
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.19, with an EV/FCF ratio of 51.86.

EV / Earnings	27.70
EV / Sales	5.75
EV / EBITDA	18.19
EV / EBIT	24.80
EV / FCF	51.86

Financial Position

The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.04.

Current Ratio	2.70
Quick Ratio	1.84
Debt / Equity	0.04
Debt / EBITDA	0.27
Debt / FCF	0.76
Interest Coverage	61.80

Financial Efficiency

Return on equity (ROE) is 10.47% and return on invested capital (ROIC) is 6.74%.

Return on Equity (ROE)	10.47%
Return on Assets (ROA)	5.98%
Return on Capital (ROIC)	6.74%
Revenue Per Employee	501,096
Profits Per Employee	104,017
Employee Count	1,567
Asset Turnover	0.41
Inventory Turnover	2.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.17% in the last 52 weeks. The beta is 0.17, so Shanghai INT Medical Instruments's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	+4.17%
50-Day Moving Average	28.49
200-Day Moving Average	27.71
Relative Strength Index (RSI)	56.43
Average Volume (20 Days)	24,360

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai INT Medical Instruments had revenue of HKD 865.39 million and earned 179.64 million in profits. Earnings per share was 1.09.

Revenue	865.39M
Gross Profit	520.58M
Operating Income	200.60M
Pretax Income	212.17M
Net Income	179.64M
EBITDA	269.42M
EBIT	200.60M
Earnings Per Share (EPS)	1.09

Balance Sheet

The company has 390.10 million in cash and 72.61 million in debt, giving a net cash position of 317.49 million or 1.80 per share.

Cash & Cash Equivalents	390.10M
Total Debt	72.61M
Net Cash	317.49M
Net Cash Per Share	1.80
Equity (Book Value)	1.82B
Book Value Per Share	10.25
Working Capital	437.78M

Cash Flow

In the last 12 months, operating cash flow was 232.92 million and capital expenditures -136.98 million, giving a free cash flow of 95.94 million.

Operating Cash Flow	232.92M
Capital Expenditures	-136.98M
Free Cash Flow	95.94M
FCF Per Share	0.55

Margins

Gross margin is 60.16%, with operating and profit margins of 23.18% and 21.91%.

Gross Margin	60.16%
Operating Margin	23.18%
Pretax Margin	24.52%
Profit Margin	21.91%
EBITDA Margin	31.13%
EBIT Margin	23.18%
FCF Margin	11.09%

Dividends & Yields

This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.99%.

Dividend Per Share	0.30
Dividend Yield	0.99%
Dividend Growth (YoY)	11.11%
Years of Dividend Growth	n/a
Payout Ratio	26.70%
Buyback Yield	0.79%
Shareholder Yield	1.78%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Shanghai INT Medical Instruments has an Altman Z-Score of 10.87.

Altman Z-Score	10.87
Piotroski F-Score	n/a